Literature DB >> 3951717

Severe acute Guillain-Barré syndrome.

A H Ropper.   

Abstract

Six of 58 consecutive patients with Guillain-Barré syndrome had an acute, severe, and prolonged initial illness, with quadriplegia in 2 to 5 days and mechanical ventilation for over 2 months. The average times in the ICU, on a ventilator, in the hospital, and in rehabilitation were 62, 141, 157, and 148 days, respectively. Four were still bedbound and ventilated at 6 months. Three (5%) were limited to a chair, and three walked unsteadily or required foot splints 2 to 3 years after onset. Only 2 of 13 other ventilated patients with slower initial progression of weakness, and none of 38 nonventilated patients were chairbound 6 months after onset (1 died at 2 months); all were walking independently by a year. Quadriplegia appearing over 2 to 5 days is associated with the most severe and prolonged weakness and, in some patients, leads to a permanent chairbound state. Improvement stops at 1 1/2 to 2 years.

Entities:  

Mesh:

Year:  1986        PMID: 3951717     DOI: 10.1212/wnl.36.3.429

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Guillain-Barré syndrome mistaken for brain stem death.

Authors:  T Hassan; C Mumford
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

2.  Abdominal pain associated with cranial nerve palsy and peripheral neuropathy.

Authors:  L K Dawson; C D Selby; K C Fearon; C J Mumford; E R Chilvers
Journal:  Postgrad Med J       Date:  1997-05       Impact factor: 2.401

Review 3.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

4.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

Review 5.  Respiratory dysfunction in Guillain-Barré Syndrome.

Authors:  David Orlikowski; Hélène Prigent; Tarek Sharshar; Frédéric Lofaso; Jean Claude Raphael
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome.

Authors:  A Hiraga; M Mori; K Ogawara; S Kojima; T Kanesaka; S Misawa; T Hattori; S Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

7.  A case of neurosarcoidosis that presented with symptoms of Guillain-Barré syndrome.

Authors:  A Oldroyd; T Dawson; J Nixon
Journal:  BMJ Case Rep       Date:  2011-04-01

8.  P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration.

Authors:  A F Hahn; T E Feasby; L Wilkie; D Lovgren
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability.

Authors:  María J Sedano; Ana Canga; Carmen de Pablos; José M Polo; José Berciano
Journal:  J Neurol       Date:  2013-01-31       Impact factor: 4.849

10.  Acute axonal idiopathic polyneuropathy: a Guillain-Barré syndrome variant?

Authors:  S Magi; M Sabatelli; T Mignogna; C Porcu; P Tonali
Journal:  Ital J Neurol Sci       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.